Skip to Main Content

Prior Authorization Medical - All Products

Please note, failure to obtain authorization may result in administrative claim denials. Buckeye Health Plan providers are contractually prohibited from holding any member financially liable for any service administratively denied by Buckeye Health Plan for the failure of the provider to obtain timely authorization.


Medical Prior Authorization Information

Medicare Prior Authorizations as of January 1, 2023 (PDF)

MEDICARE/Wellcare By Allwell Inpatient escalations:

For all Medicare Outpatient authorization escalations:  800-225-2573 Ext 6035986 

Medicare Part B Drug List as of January 1, 2023 (PDF)

Medicare Prior Authorization Changes Effective 7-1-22



Prior Authorization Updates up to May 2021

See the PA Latest News for more recent updates.

Ambetter from Buckeye Health Plan has Reduced Prior Authorization Requirements

In response to your feedback, Buckeye has removed 25 services from our prior authorization list effective March 31, 2021. View the full list (PDF)

Buckeye Health Plan has Reduced Prior Authorization Requirements

In response to your feedback, we have removed 22 services from our prior authorization list effective March 31, 2021. View the full list (PDF) and review our Medicaid PA Quick Reference Guide for more information on prior authorization and important contacts. 

InterQual Connect™

Buckeye Health Plan - Secure Provider Portal: effective April 15, 2021

Buckeye values the relationships we have with our provider partners and works to ensure that doing business with us is easy and straightforward. A key component of meeting provider needs is our secure Provider Portal, which enables providers to conduct business with Buckeye from the convenience of their desktops seamlessly and in real time. 

New Features

We are pleased to announce effective April 15, 2021, the integration of an exciting new tool, InterQual Connect™ in our Secure Provider Portal. Adding features that will simplify the provider experience and offers several new capabilities. 

  • Streamlines web authorization request
  • Provides easy access to InterQual Connect to complete medical review
    • Completed InterQual medical review will automatically be included with your web authorization submission
    • Possible same-day approval based on outcome of a completed InterQual medical necessity review 
  • Identifies non-submitted Service Lines and provides reason for non-submittal

We believe the enhancements to our Provider Portal will create a more user-friendly experience and enhance your ease of doing business with Buckeye. We hope you will take a moment to explore them.

Please contact Provider Services at 866.296.8731 with any questions you may have. 


Buckeye Health Plan has Reduced Prior Authorization Requirements

In response to your feedback, Buckeye has removed 154 servcies from our prior authorization list. View the full list (PDF) and review our Quick Reference Guides for more information on prior authorization and important contacts. 


Important Updates Effective January 1, 2020 - Allwell from Buckeye Health Plan

Allwell from Buckeye Health Plan requires prior authorization as a condition of payment for many services.  This Notice contains information regarding such prior authorization requirements and is applicable to all Medicare products offered by Allwell.

Allwell from Buckeye Health Plan is committed to delivering cost effective quality care our members.  This effort requires us to ensure that our members receive only treatment that is medically necessary according to current standards of practice.  Prior authorization is a process initiated by the ordering physician in which we verify the medical necessity of a treatment in advance using independent objective medical criteria. Please see the provider notice and list of procedures requiring prior authorization: 


Important Updates Effective September 3, 2019

Buckeye Health Plan is pleased to announce its collaboration with New Century Health (NCH), an oncology quality management company, to implement a new oncology pre-approval program, Buckeye Health Plan Oncology Pathway Solutions. The program will simplify the administrative process for providers to support the effective delivery of quality patient care.

Beginning September 3, 2019, all oncology-related chemotherapeutic drugs and supportive agents will require clinical review by NCH before being administered in a physician’s office, outpatient hospital or ambulatory setting. This prior authorization requirement applies to both pharmacy dispensed and office administered medication requests for all Buckeye Health Plans Medicaid members ages 18 and over. Please see the provider notice and accompanying handouts below:


Important Updates Effective August 15, 2019

Buckeye Health Plan is pleased to announce the launch of a new and innovative Surgical Quality and Safety Management Program, effective August 15, 2019. The program is designed to work collaboratively with physicians to promote patient safety through the practice of high quality and cost-effective care for BHP members undergoing Cardiac Surgical Procedures. Please see the provider notice and accompanying handout below: 


Important Updates Effective January 1, 2019

On January 1, 2019, prior authorization will be required for the below J codes in all care settings including inpatient hospital and outpatient hospital or ambulatory care center:

  • Fluocinolone acetonide, intravitreal implant, J7311
  • Fluocinolone acetonide intravitreal implant, J7313
  • Hyaluronan or derivative, gel-syn, J7328
  • Tacrol Envarsus xr, J7503
  • Netupitant palonosetron, J8655
  • Aldesleukin, J9015
  • Belinostat, J9032
  • Bendeka, J9034
  • Bortezomib, J9041
  • Cabazitaxel, J9043
  • Cyclophosphamide, J9070
  • Daratumumab, J9145
  • Leuprolide acetate implant, J9219
  • Olaratumab, J9285
  • Obinutuzumab, J9301
  • Ramucirumab, J9308
  • Temsirolimus, J9330
  • Pegloticase, J2507



Important Updates Effective April 15, 2015


Important Updates Effective November 1, 2014


Update Posted December 18, 2012

We know that recently you’ve been experiencing some issues with J9035 and J9355 authorizations and we apologize for any inconveniences this may have caused. Our goal is to continue to work with you to help ensure that you are able to provide your patients the best care possible.

Effective, February 1, 2013, all participating Hematologists and Oncologists will be required to receive prior authorization before administering injectable drugs with costs over $250. If drugs are administered without authorization, the claim will be denied and the provider will not receive payment. There are some exceptions to this policy, so please call Provider Services to determine if a drug needs prior authorization.

We are reviewing denials weekly for claims that have been denied due to the new authorization requirements and will override these denials until January 31.